LDOS at a glance
Leidos (LDOS, SEC CIK 1336920) filed its latest 10-K annual report on February 17, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 3, 2026 and Form 4 insider filings as recently as November 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended January 2, 2026 (FY2025), Leidos (LDOS) reported revenue of $17.1 billion (up 3.2% from FY2024) and net income of $1.4 billion. Diluted EPS was $11.14.
- As of September 30, 2026, 39 institutional investment managers tracked by SignalX reported holding Leidos (LDOS) shares worth $6.1 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Stevens Roy E on November 17, 2026 of 2,287 shares at $130.95 per share.
- In the last 90 days, LDOS insiders reported 0 open-market purchases ($0) and 2 open-market sales ($440K) on Form 4, a net sale of $440K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $17.1B
- +3.2% vs prior year
- Insiders · 90 days
- 0 buys · 2 sells
- Net −$440K
- 13F holders
- 39 funds
- $6.1B · +0 vs prior quarter
- Latest 8-K
- Nov 3, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Jan 2, 2026
Business Overview
- Core business model: Provides technology, engineering, and scientific services to government and commercial customers, with emphasis on defense, intelligence, and health sectors
- Strategic emphasis on evolving ESG practices amid increased regulatory and stakeholder attention, driving new compliance costs and reputational risk management efforts
- Backlog $49.0B (including $9.7B funded) as of Jan 2, 2026, with revenues dependent on contract realization and subject to government termination rights
- Profitability risk heightened by 43% revenues from Fixed-Price contracts, requiring precise cost estimates amid inflation, subcontractor performance, and force majeure challenges
- Noteworthy focus on operational risks from employee/subcontractor misconduct, data security lapses, and talent retention amid regulatory scrutiny and executive compensation restrictions
Risk Factors
- Regulatory risk: Non-compliance with U.S. government procurement laws may trigger penalties including contract termination, suspension, or debarment from federal contracting
- Macroeconomic threat: Budget Control Act of 2011 and Fiscal Responsibility Act of 2023 impose caps, risking reduced defense spending and DoW contract revenue (49% of total)
- Supply chain vulnerability: Inflation and global supply disruptions raise costs, underpricing risk on fixed-price multi-year U.S. government contracts, pressuring profitability
- Competitive risk: Larger competitors and federal contract research centers intensify competition, potentially reducing contract awards and market share
- Financial risk: Revenues heavily reliant (87%) on U.S. government contracts with budget delays and continuing resolutions risking payment delays and government shutdown impacts
Management Discussion & Analysis
- Revenue $17.174B, up 3% YoY from $16.662B driven by program wins, volume increases, and a $60M acquisition contribution
- Operating margin 12.3% vs 11.0%; Operating income $2.109B, up 15% YoY from $1.827B
- Best segment Health & Civil: revenue $5.069B (+1%), operating margin 23.7% vs 21.8%, operating income $1.202B (+10%); Worst segment Commercial & International: revenue $2.315B (+3%), operating margin 7.2% vs 4.6%, operating income $166M (+60%) but lowest margin
- Cash flow from operations $1.750B (+$315M); Capital allocation includes $211M dividends, $400M open market stock repurchases, and $500M accelerated share repurchase, plus $293M acquisition cash outflow
- Forward outlook notes risks from U.S. government spending uncertainty and competitive pressures; liquidity sufficient for next 12 months including $1.5B amended credit facility and $1.4B bridge loan for $2.4B Entrust acquisition
AI summary of the LDOS 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Oct 2, 2026
Management Discussion & Analysis
- Revenue $4.630B, up 3.6% YoY from $4.469B
- Operating margin 11.9% vs 12.0% YoY, net income $1.104B vs $1.127B
- Homeland best performer: revenue $1.024B, up 32.1%; Health weakest: $1.068B, down 11.7%
- Operating cash flow decreased $188M YoY; investing outflow $48M, financing outflow $549M
- Federal funding secured through December 11, 2026; potential shutdown risk after continuing resolution expiration
Risk Factors
- No material changes to previously disclosed risk factors since the January 2, 2026 Form 10-K
- Carried-forward risks remain Leidos’s principal disclosed risk exposures across regulatory, operational, market, and financial categories
AI summary of the LDOS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q3 fiscal 2026 results announced for quarter ended October 2, 2026
- Investor-focused financial details contained in Exhibit 99.1 press release
Item EX-99.1: Item EX-99.1
- Q3 revenue $4.63B, up 4% YoY, with net income $413M and diluted EPS $3.28
- Non-GAAP EPS $3.62, up 19% YoY, while adjusted EBITDA margin improved to 13.9%
Item 1.01: Entry into a Material Definitive Agreement
- AHP Investor controls the JV board, while Leidos retains minority representation and protective rights over material actions
- JV cash distributions determined by the board, required at least annually, creating potential recurring liquidity for investors
Item EX-99.1: Item EX-99.1
- Completed joint venture with Altaris, combining Leidos SES and Analogic security-screening businesses
- Analogic-branded JV targets airport, border and critical-infrastructure screening markets worldwide
Item 7.01: Regulation FD Disclosure
- Leidos announced JV closing through an October 5, 2026 press release
- Joint venture completion marks a material strategic transaction for Leidos
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Board expanded to 11 members with Jeffery S. McElfresh elected director effective October 1, 2026
- McElfresh designated independent under New York Stock Exchange requirements
AI summaries of LDOS 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for LDOS
Don't miss the next LDOS filing
- Alerts as it files. A push when LDOS files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut LDOS, by share count.
- Ask anything. An AI agent that reads every LDOS filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Stevens Roy E | M | Nov 17, 2026 | 6,611 | - |
| Stevens Roy E | M | Nov 17, 2026 | 8,746 | $89.08 |
| Stevens Roy E | Sell | Nov 17, 2026 | 2,287 | $130.95 |
| Stevens Roy E | M | Nov 17, 2026 | 8,746 | - |
| Stevens Roy E | F | Nov 17, 2026 | 13,070 | $132.00 |
| Stevens Roy E | M | Nov 17, 2026 | 6,611 | $107.57 |
| KRAEMER HARRY M JANSEN JR | A | Oct 7, 2026 | 297.226 | - |
| SHAPARD ROBERT S | A | Sep 30, 2026 | 5.701 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $15.3B | $16.6B | $17.1B |
| Operating Income | $621.0M | $1.8B | $2.1B |
| Net Income | $199.0M | $1.3B | $1.4B |
| Op. Margin | 4.0% | 11.0% | 12.3% |
| Net Margin | 1.3% | 7.6% | 8.5% |
| Balance Sheet | |||
| Total Assets | $12.7B | $13.1B | $13.5B |
| Equity | $4.2B | $4.4B | $4.9B |
| ROE | 4.7% | 28.4% | 29.5% |
| Per Share | |||
| EPS | $1.44 | $9.22 | $11.14 |
| Cash Flow | |||
| Operating CF | - | $1.4B | $1.8B |
Source: XBRL data in Leidos (LDOS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate LDOS share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 39 | $6.13B |
| Q2 2026 | 39 | $5.32B |
| Q1 2026 | 41 | $7.95B |
| Q4 2025 | 40 | $9.25B |
| Q3 2025 | 40 | $10.81B |
| Q2 2025 | 39 | $8.45B |
| Q1 2025 | 37 | $5.66B |
| Q4 2024 | 31 | $5.05B |
- AQR Capital Management+2.08M (+251%)
- Two Sigma Investments+228.1K (+124%)
- Dimensional Fund Advisors+177.0K (+8%)
- Morgan Stanley+23.1K (+1%)
- JPMorgan Chase & Co+18.0K (+0%)
- Citadel Advisors LLC−420.3K (-68%)
- State Street Corp−285.2K (-5%)
- Invesco Ltd−274.2K (-9%)
- Vanguard Portfolio Management LLC−201.2K (-4%)
- BlackRock−180.7K (-2%)
- FMR LLC (Fidelity)−1.73M
- Equitable Holdings Inc−3.2K
Source: 13F-HR filings on SEC EDGAR (aggregated from 306 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
LDOS filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 19, 2026 | - | - | - |
| 8-K | Nov 3, 2026 | - | Analysis | - |
| 10-Q | Nov 3, 2026 | Oct 2, 2026 | Analysis | |
| 4 | Oct 9, 2026 | - | - | - |
| 8-K | Oct 5, 2026 | - | Analysis | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 8-K | Oct 1, 2026 | - | Analysis | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Aug 13, 2026 | - | - | - |
| 4 | Aug 6, 2026 | - | - | - |
| 4 | Aug 6, 2026 | - | - | - |
| 4 | Aug 6, 2026 | - | - | - |
| 10-Q | Aug 4, 2026 | Jul 3, 2026 | Analysis | |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 4 | Jul 7, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | May 12, 2026 | - | - |
Related Industrials companies
- MMM · 3MSurgical & Medical Instruments & Apparatus
- AOS · A. O. SmithHousehold Appliances
- AIR · AAR CORPAircraft & Parts
- ABM · ABM INDUSTRIES INC /DE/Services-To Dwellings & Other Buildings
- ACU · ACME UNITED CORPCutlery, Handtools & General Hardware
- ADT · ADT IncServices-Detective, Guard & Armored Car Services
- AEBI · Aebi Schmidt Holding AGConstruction Machinery & Equip
- AVAV · AeroVironment IncAircraft
LDOS SEC filings: frequently asked questions
Are LDOS insiders buying or selling?
In the last 90 days, Leidos (LDOS) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $440,328 by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold LDOS stock?
As of September 30, 2026, the largest Leidos (LDOS) holders among the 13F filers tracked by SignalX were BlackRock ($1.2 billion), Vanguard Capital Management LLC ($999.2 million), State Street Corp ($730.1 million), Vanguard Portfolio Management LLC ($629.6 million), JPMorgan Chase & Co ($474.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was LDOS's revenue in fiscal year 2025?
For the fiscal year ended January 2, 2026 (FY2025), Leidos (LDOS) reported revenue of $17.1 billion (up 3.2% from FY2024) and net income of $1.4 billion. Diluted EPS was $11.14. The figures come from the XBRL data in the 10-K.
What are the main risks in LDOS's latest 10-K?
In the 10-K filed February 17, 2026, Leidos (LDOS) flagged: Regulatory risk: Non-compliance with U.S. government procurement laws may trigger penalties including contract termination, suspension, or debarment from federal contracting. Macroeconomic threat: Budget Control Act of 2011 and Fiscal Responsibility Act of 2023 impose caps, risking reduced defense spending and DoW contract revenue (49% of total). (AI summary of the Risk Factors section.)
What did LDOS report in its latest 8-K?
Leidos (LDOS) filed an 8-K on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 fiscal 2026 results announced for quarter ended October 2, 2026.
What are the latest LDOS SEC filings?
Leidos (LDOS) filed its latest 10-K annual report on February 17, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 3, 2026 and a Form 4 insider filing on November 19, 2026.
What is LDOS's SEC CIK number?
Leidos (LDOS)'s SEC Central Index Key (CIK) is 1336920. EDGAR lists every LDOS filing under that number.
Ask anything about LDOS
The research agent reads LDOS's filings, financials, insider trades and 13F holders, then answers with sources.